tiprankstipranks
C4 Therapeutics (CCCC)
NASDAQ:CCCC
US Market

C4 Therapeutics (CCCC) Technical Analysis

393 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
2Neutral
13Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
C4 Therapeutics’s (CCCC) Moving Averages Convergence Divergence (MACD) indicator is -0.49, suggesting C4 Therapeutics is a Buy.
C4 Therapeutics’s (CCCC) 20-Day exponential moving average is 4.81, while C4 Therapeutics’s (CCCC) share price is $4.24, making it a Sell.
C4 Therapeutics’s (CCCC) 50-Day exponential moving average is 5.66, while C4 Therapeutics’s (CCCC) share price is $4.24, making it a Sell.

C4 Therapeutics (CCCC) Pivot Points

Jun 22, 2024, 02:52 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.80
3.86
3.95
4.01
4.11
4.17
4.26
Fibonacci
3.86
3.92
3.95
4.01
4.07
4.11
4.17
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

C4 Therapeutics (CCCC) Moving Averages

Jun 22, 2024, 02:52 PM
Period
Simple
Exponential
MA5
4.18Buy
4.25Sell
MA10
4.50Sell
4.45Sell
MA20
4.79Sell
4.81Sell
MA50
5.80Sell
5.66Sell
MA100
7.05Sell
6.00Sell
MA200
5.04Sell
4.91Sell
C4 Therapeutics’s (CCCC) 10-Day exponential moving average is 4.45, while C4 Therapeutics’s (CCCC) share price is $4.24, making it a Sell.
C4 Therapeutics’s (CCCC) 100-Day exponential moving average is 6.00, while C4 Therapeutics’s (CCCC) share price is $4.24, making it a Sell.
C4 Therapeutics’s (CCCC) stock price is $4.24 and C4 Therapeutics’s (CCCC) 50-day simple moving average is 5.80, creating a Sell signal.
C4 Therapeutics’s (CCCC) stock price is $4.24 and C4 Therapeutics’s (CCCC) 100-day simple moving average is 7.05, creating a Sell signal.
C4 Therapeutics’s (CCCC) stock price is $4.24 and C4 Therapeutics’s (CCCC) 200-day simple moving average is 5.04, creating a Sell signal.

C4 Therapeutics (CCCC) Technical Indicators

Jun 22, 2024, 02:52 PM
Name
Value
Implied Action
RSI (14)
29.72
Buy
STOCH (9,6)
17.34
Buy
STOCHRSI (14)
17.16
Buy
MACD (12,26)
-0.49
Buy
ADX (14)
49.56
Neutral
Williams %R
-73.17
Buy
CCI (14)
-121.58
Buy
ATR (14)
0.32
-
Ultimate Oscillator
35.25
Neutral
ROC
-15.20
Sell
C4 Therapeutics’s (CCCC) Relative Strength Index (RSI) is 29.72, creating a Buy signal.
C4 Therapeutics’s (CCCC) Trend Strength Indicator (ADX) is 49.56, creating a Neutral signal.
C4 Therapeutics’s (CCCC) Commodity Channel Index (CCI) is -121.58, creating a Buy signal.
C4 Therapeutics’s (CCCC) Price Rate of Change (ROC) is -15.20, creating a Sell signal.

FAQ

Is CCCC a Buy, Hold, or Sell?
Based on CCCC’s technical indicators, CCCC is a Sell.
    What is CCCC’s RSI (14)?
    CCCC’s RSI (14) is 29.72, which suggests CCCC is a Buy.
      What is CCCC’s MACD?
      CCCC’s MACD is -0.49, which suggests CCCC is a Buy.
        What is CCCC’s 5-day moving average?
        CCCC’s 5-day moving average is 4.18, which suggests CCCC is a Buy.
          What is CCCC’s 20-day moving average?
          CCCC 20-day moving average is 4.79, which suggests CCCC is a Sell.
            What is CCCC’s 50-day moving average?
            CCCC’s 50-day moving average is 5.80, which suggests CCCC is a Sell.
              What is CCCC’s 200-day moving average?
              CCCC’s 200-day moving average is 5.04, which suggests CCCC is a Sell.
                What is CCCC’s Williams % R (14)?
                CCCC’s Williams % R (14) is -73.17, which suggests CCCC is a Buy.
                  What is CCCC’s CCI (14)?
                  CCCC’s CCI (14) is -121.58, which suggests CCCC is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis